Publication | Closed Access

Combination therapy of metformin and p-coumaric acid mitigates metabolic dysfunction associated with obesity and nonalcoholic fatty liver disease in high-fat diet obese C57BL/6 mice

Metabolic DisorderFatty Liver DiseaseObesityMetabolic SyndromeP-coumaric AcidMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseMetabolic DysfunctionHealth SciencesMetabolic Associated SteatohepatitisLiver PhysiologyPharmacologyMetabolic ComplicationPhysiologyDiabetesMetabolic RegulationCombination TherapyMetabolismMedicine